These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 9048625

  • 1. 17-beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo.
    Visser-Wisselaar HA, Van Uffelen CJ, Van Koetsveld PM, Lichtenauer-Kaligis EG, Waaijers AM, Uitterlinden P, Mooy DM, Lamberts SW, Hofland LJ.
    Endocrinology; 1997 Mar; 138(3):1180-9. PubMed ID: 9048625
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin receptor manipulation.
    Visser-Wisselaar HA, Hofland LJ, van Uffelen CJ, van Koetsveld PM, Lamberts SW.
    Digestion; 1996 Mar; 57 Suppl 1():7-10. PubMed ID: 8813458
    [Abstract] [Full Text] [Related]

  • 3. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
    Hofland LJ, van Koetsveld PM, Wouters N, Waaijers M, Reubi JC, Lamberts SW.
    Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
    [Abstract] [Full Text] [Related]

  • 4. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
    Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C, Epelbaum J.
    Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
    [Abstract] [Full Text] [Related]

  • 5. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
    Lamberts SW, van Koetsveld P, Verleun T.
    Cancer Res; 1987 Jul 15; 47(14):3667-71. PubMed ID: 3594432
    [Abstract] [Full Text] [Related]

  • 6. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
    Xu Y, Song J, Berelowitz M, Bruno JF.
    Endocrinology; 1996 Dec 15; 137(12):5634-40. PubMed ID: 8940394
    [Abstract] [Full Text] [Related]

  • 7. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S, Kamegai J, Johnson TA, Frohman LA, Kineman RD.
    Endocrinology; 2000 Oct 15; 141(10):3556-63. PubMed ID: 11014208
    [Abstract] [Full Text] [Related]

  • 8. Differences in the mechanism of the inhibitory actions of catecholestrogens, tamoxifen and high concentrations of estrogens on prolactin release by cultured rat pituitary tumor cells.
    Lamberts SW, Verleun T.
    Eur J Cancer Clin Oncol; 1987 Aug 15; 23(8):1117-23. PubMed ID: 2820746
    [Abstract] [Full Text] [Related]

  • 9. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW.
    J Clin Endocrinol Metab; 2004 Apr 15; 89(4):1577-85. PubMed ID: 15070915
    [Abstract] [Full Text] [Related]

  • 10. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M, Lawnicka H, Pisarek H, Kunert-Radek J, Radek M, Culler MD.
    J Physiol Pharmacol; 2007 Mar 15; 58(1):179-88. PubMed ID: 17440235
    [Abstract] [Full Text] [Related]

  • 11. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    Hofland LJ, De Herder WW, Visser-Wisselaar HA, Van Uffelen C, Waaijers M, Zuyderwijk J, Uitterlinden P, Kros MJ, Van Koetsveld PM, Lamberts SW.
    J Clin Endocrinol Metab; 1997 Sep 15; 82(9):3011-8. PubMed ID: 9284735
    [Abstract] [Full Text] [Related]

  • 12. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.
    Schaer JC, Waser B, Mengod G, Reubi JC.
    Int J Cancer; 1997 Mar 04; 70(5):530-7. PubMed ID: 9052751
    [Abstract] [Full Text] [Related]

  • 13. 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells.
    Kimura N, Hayafuji C, Konagaya H, Takahashi K.
    Endocrinology; 1986 Sep 04; 119(3):1028-36. PubMed ID: 2874016
    [Abstract] [Full Text] [Related]

  • 14. Pituitary somatostatin receptor (sst)1-5 expression during rat development: age-dependent expression of sst2.
    Reed DK, Korytko AI, Hipkin RW, Wehrenberg WB, Schonbrunn A, Cuttler L.
    Endocrinology; 1999 Oct 04; 140(10):4739-44. PubMed ID: 10499533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.